Abstract 【Objective】To investigate the clinical efficacy of L-carnitine combined with astragalus injection in the treatment of acute viral myocarditis (AVM) and explore its effect on serum myocardial enzyme markers. 【Methods】The clinical data of 104 patients with acute viral myocarditis received admitted our hospital were retrospectively studied. According to the different methods of administration, they were divided into the observation group (L-carnitine combined with Astragalus injection) and the control group (L-carnitine treatment only). There were 52 cases in each group. The therapeutic effects of the two groups were compared. Levels of serum myocardial enzyme markers and incidence of adverse reactions before and after treatment were compared as well. 【Results】After 2 weeks of treatment, the total effective rate of the observation group was 80.7% (42/52), which was higher than that of the control group 59.6% (31/52), and the difference was statistically significant (P<0.05). The levels of serum CK, CK-MB and CTnT in the two groups after treatment were lower than those before treatment; the CK, CK-MB and CTnT levels of the observation group were lower than those of the control group. The difference was statistically significant (P<0.05). There were no significant differences in the incidence of adverse reactions such as headache, allergic reaction, liver and kidney function damage, and dyspnea in the two groups (P>0.05).【Conclusion】L-carnitine combined with astragalus injection is effective in the treatment of acute viral myocarditis. It can effectively improve cardiac function, decrease levels of serum myocardial enzyme markers but not increase drug adverse reactions, which is worthy of clinical application.
WANG Xiao-xia,LIU Yue-ying,XU Wen-gang. Effect of L-Carnitine Combined with Astragalus Injection on Serum Myocardical Enzyme Markers in the Treatment of Acute Viral Myocarditis[J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(9): 1756-1758.
2019, Vol. 36 
